Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jul 3, 2024
- Accession no.
- 0001127602-24-020038
- Filed
- Jul 3, 2024
- Trade date
- Jul 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $150.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2024 | Common Stock | SSaleDisposed | −3,000 | $50.08 | −$150,240 | 462,474 | Direct | |
| Jul 1, 2024 | Common Stock | FTax withholdingDisposed | −508 | $50.19 | −$25,496.52 | 461,966 | Direct | |
| Jul 1, 2024 | Common Stock | FTax withholdingDisposed | −947 | $50.19 | −$47,529.93 | 461,019 | Direct | |
| Jul 1, 2024 | Common Stock | FTax withholdingDisposed | −1,475 | $50.19 | −$74,030.25 | 459,544 | Direct | |
| Jul 1, 2024 | Common Stock | FTax withholdingDisposed | −1,292 | $50.19 | −$64,845.48 | 458,252 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.